This journal discusses the treatment of diabetic wounds and how to heal them and protect these wounds form microbial infection. Historically the treatment of Diabetic wounds requires a very large amount of growth factors so the researchers developed a strategy using a payload comprising of Eudragit RL/RS 100 nanofibers carrying gentamicin sulphate (GS) a bacterial inhibitor in a concentrate with the human epidermal growthfactor (rhEGF), a wound healing accelerator. This is important because diabetes is a barrier to proper wound healing that can lead to infection or worst case amputation. They used scanning electron microscopy, fourier transform infrared, spectroscopy and X-ray diffraction in order to characterize this new fabricated nanoscaffold. The subsequent research that followed this experiment showed much improvement to healing wounds then traditional bandages.